Compounds > fluoxetine

fluoxetine and n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine

fluoxetine has been researched along with n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Callaway, CW; Geyer, MA1
Callaway, CW; Geyer, MA; Gold, LH; Johnson, MP; Nichols, DE1
Brownfield, MS; Levy, AD; Li, Q; Murakami, I; Nichols, DE; Stall, S; Van de Kar, LD1
Marona-Lewicka, D; Nichols, DE1

Other Studies

4 other study(ies) available for fluoxetine and n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine

ArticleYear
Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.
    European journal of pharmacology, 1992, Apr-07, Volume: 214, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Corpus Striatum; Fluoxetine; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats; Rats, Inbred Strains

1992
Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.
    Psychopharmacology, 1991, Volume: 104, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Biogenic Amines; Brain Chemistry; Dose-Response Relationship, Drug; Exploratory Behavior; Fluoxetine; Male; Motor Activity; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin

1991
Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Fluoxetine; Indans; Male; Oxytocin; Prolactin; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vasopressins

1996
Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
    Psychopharmacology, 1998, Volume: 138, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Antidepressive Agents, Second-Generation; Citalopram; Conditioning, Operant; Discrimination, Psychological; Fluoxetine; Indans; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists

1998